Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: With mean follow-up of 3.5 years

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 8, 2013, Pages 1621-1627

  Mmeje, Chinedu O ^a   Nunez Nateras, Rafael ^a   Nielsen, Matthew E ^b   Pruthi, Raj S ^b   Smith, Angela ^b   Wallen, Eric M ^b   Humphreys, Mitchell R ^a   Woods, Michael E ^b   Castle, Erik P ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder; Cystectomy; Laparoscopy; Robotics; Urinary bladder neoplasm

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DENSITY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; ROBOTICS; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; URINARY DIVERSION;

BLADDER; CYSTECTOMY; LAPAROSCOPY; ROBOTICS; URINARY BLADDER NEOPLASM;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ROBOTICS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84886259898     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.03.001     Document Type: Article

References (23)

1. Jemal A., Bray F., Center M.M., Center M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-675.
3. Herr H.W. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003, 169:943-945.
4. Pruthi R.S., Nielsen M.E., Nix J., et al. Robotic radical cystectomy for bladder cancer: Surgical and pathological outcomes in 100 consecutive cases. J Urol 2010, 183:510-514.
5. Wang G.J., Barocas D.A., Raman J.D., et al. Robotic vs. open radical cystectomy: Prospective comparison of perioperative outcomes and pathologic measures of early oncologic efficacy. BJU Int 2007, 101:89-93.
6. Ng C.K., Kauffman E.C., Lee M.M., et al. A comparison of postoperative complications in open vs. robotic cystectomy. Eur Urol 2010, 57:274-281.
7. Martin A.D., Nunez R.N., Pacelli A., et al. Robot-assisted radical cystectomy: Intermediate survival results at a mean follow-up of 25 months. BJU Int 2009, 105:1706-1709.
8. Cancer staging Manual 2002, 335. Urinary bladderin American Joint Committee on Cancer (AJCC), Springer, New York. 6th ed.
9. Castle E.P., Woods M., Lowentritt B.H., et al. Robotic assisted radical cystectomy. Smith's textbook of endourology 2007, 965-970. BC Decker, Lewiston. 2nd ed, Chap 11. A.D. Smith (Ed.).
10. Pruthi R.S., Wallen E.M. Robotic assisted laparoscopic radical cystoprostatectomy: Operative and pathological outcomes. J Urol 2007, 178:814-818.
11. Huang J., Tianxin L., Liu H., et al. Laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer: Oncologic results of 171 cases with a median 3-year follow-up. Eur Urol 2010, 58:442-449.
12. Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003, 21:690-696.
13. Hautmann R.E., Gschwend J.E., de Petriconi R.C., et al. Cystectomy for transitional cell carcinoma of the bladder: Results of a surgery only series in the neobladder era. J Urol 2006, 176:486-492. discussion 491.
14. Stein J.P., Cai J., Groshen S., et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: the concept of lymph node density. J Urol 2003, 170:35-41.
15. Manoharan M., Ayyathurai R., Soloway M.S. Radical cystectomy for urothelial carcinoma of the bladder: An analysis of perioperative and survival outcome. BJU Int 2009, 104:1227-1232.
16. Konety B.R., Joslyn S.A., O'Donnell M.A. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the surveillance, epidemiology and end results program data base. J Urol 2003, 169:946-950.
17. Herr H.W., Bochner B.H., Dalbagni G., et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002, 167:1295-1298.
18. Poulson A.L., Horn T., Stevenson K. Radical cystectomy: Extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998, 160:2015-2019. Discussion 2020.
19. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of BA06 30894 trial. J Clin Oncol 2011, 29:2171-2177. International Collaboration of Trialists, Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group), European rganization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group, et al.
20. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003, 349:859-866.
21. Raj G.V., Karavadia S., Schlomer B., et al. Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. Cancer 2011, 117:276-282.
22. Dotan Z.A., Kavanagh K., Yossepowitch O., et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 2007, 178:2308-2312. Discussion 2313.
23. Sonpavde G., Khan M.M., Lerner S.P., et al. Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer. J Urol 2011, 185:456-461.